Opioid cost: A global problem

Palliative Medicine

Volumn 19, Issue 6, 2005, Pages 504-

  Bruera, Eduardo D ^a   de Lima, Liliana ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b International Association for Hospice and Palliative Care   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE; MORPHINE; OPIATE;

ANALGESIA; CANCER PAIN; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DRUG CHOICE; DRUG COST; DRUG USE; EUROPE; HUMAN; LETTER; PALLIATIVE THERAPY; PATIENT CARE; SIDE EFFECT; SLOW RELEASE FORMULATION;

ANALGESICS, OPIOID; DRUG COSTS; HUMANS; PALLIATIVE CARE;

EID: 26444452072     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1177/026921630501900612     Document Type: Article

References (7)

1. De Conno F, Ripamonti C, Brunelli C. Opioid purchases and expenditure in nine western European countries: ‘Are we killing off morphine? ’ Palliat Med 2005; 19: 179–184.
2. De Lima L, Sweeney C, Palmer JL, Bruera E. Potent analgesics are more expensive for patients in developing countries: a comparative study. J Pain Palliat Care Pharmacother 2004; 19: 59–70.
3. Stjernsward J, Bruera E, Joranson D, et al. Opioid availability in Latin America: the declaration of Florianopolis. J Palliat Care 1994; 10: 11–14.
4. De Lima L, Bruera E, Joranson D, Vanegas G, Cepeda S, Quesada L. Opioid availability in Latin America: the Santo Domingo report – progress since the declaration of Florianopolis. J Pain Symptom Manage 1997; 13: 213–219.
5. Ripamonti C. Pharmacology of opioid analgesia: clinical principals. In Bruera E, Portenoy RK eds. Cancer pain assessment and management. Cambridge, UK: Cambridge University Press, 2003.
6. Ripamonti C. Methadone: an orphan drug? J Palliat Med 2004; 7: 73–74.
7. Bruera E, Palmer JL, Bosnjak S, et al. Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized double-blind study. J Clin Oncol 2004; 22: 185–192.